UK:
Amending Legislation On Application Of The Banking Act 2009 To UK-Based CCPs And Clearing Houses
01 April 2015
Shearman & Sterling LLP
To print this article, all you need is to be registered or login on Mondaq.com.
On February 24, 2015, secondary legislation was enacted which
amends the Financial Services and Markets Act 2000 (Over the
Counter Derivatives, Central Counterparties and Trade Repositories)
Regulations 2013. The amending regulations correct the original
legislation and ensure that the special resolution regime under the
Banking Act 2009 applies to UK-based CCPs regardless of whether or
not they are authorized under the European Market Infrastructure
Regulation, from March 18, 2015 until such time as the CCP becomes
authorized. The amending regulations come into force on March 18,
2015. The special resolution regime under the Banking Act 2009 will
apply to all EMIR authorized CCPs upon that authorization.
The amending regulations are available at: http://www.legislation.gov.uk/uksi/2015/348/pdfs/uksi_20150348_en.pdf.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Finance and Banking from UK
Asset Recovery Comparative Guide
Bird & Bird
Asset Recovery Comparative Guide for the jurisdiction of UK, check out our comparative guides section to compare across multiple countries
FCA's Consultation Paper
Cadwalader, Wickersham & Taft LLP
Since 3 January 2018, firms that provide portfolio management or investment advice on an independent basis must pay for the research they obtain...
Regulation Round Up
Proskauer Rose LLP
Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation.
FCA To Permit Research Bundling
Akin Gump Strauss Hauer & Feld LLP
The Financial Conduct Authority (FCA) is seeking views on proposed rules that would allow asset managers to opt for bundled payments for third-party investment research, reversing a significant aspect of the UK's implementation of research rules under the Markets in Financial Instruments Directive (MiFID II).